Healthcare resource use and costs reduction with aripiprazole once-monthly in schizophrenia

Ambition, a real-world study

Bibliographic Data

ID15528974
AuthorsVanessa Sánchez‐Gistau (0000-0002-8635-7144, Universitat Rovira i Virgili), Vanessa Sanchez-Gistau, María José Moreno (0009-0000-7276-5190, Lundbeck (Spain)), Susana Gómez-Lus (Lundbeck (Spain)), Antoni Sicras-Mainar, Antoni Sicras‐Mainar (0000-0002-8232-293X, corresponding author), Benedicto Crespo-Facorro, Benedicto Crespo‐Facorro (0000-0003-0033-7132, Centro de Investigación Biomédica en Red de Salud Mental)
Year2023
Volume14
Pages1207307-1207307
Publication date2023-08-04
Open AccessYes
TypeARTICLE
VenueFrontiers in Psychiatry (JOURNAL)
Journal identifiersISSN: 1664-0640 • E-ISSN: 1664-0640
PublisherFrontiers Media (PUBLISHER • CH)
DOI10.3389/fpsyt.2023.1207307
PMID37599866
OpenAlexW4385577721
LanguageEN
References cited49

Aripiprazole once monthly reduces the number and duration of hospitalizations, together with the treatment costs of schizophrenia, as it reduces the use of healthcare resources and productivity losses in these individuals

Aripiprazole · Cohort · Cohort study · Confidence interval · Environmental health · Health care · Medical record · Population · Propensity score matching · Psychiatry · Retrospective cohort study · Schizophrenia (object-oriented programming · Health Systems, Economic Evaluations, Quality of Life · Medicine · Pharmaceutical Practices and Patient Outcomes · Schizophrenia research and treatment · Emergency Medicine · Internal Medicine · Pediatrics

Tools

Open DOIOpen Access